TriangleFOR PATIENTS · SOURCE READING
Certain factors affect prognosis (chance of recovery) and treatment options.
Source: Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
NCI-linked patient version: mycosis fungoides and Sezary syndrome subset Patient source covers mycosis fungoides/Sezary syndrome; do not apply to all other cutaneous T-cell lymphomas.
The prognosis and treatment options depend on the following:
Source links and citations
The stage of the cancer.
Source links and citations
The type of lesion (patches, plaques, or tumors).
The patient's age and sex.
Mycosis fungoides and Sézary syndrome are hard to cure. Treatment is usually palliative, to relieve symptoms and improve the quality of life. Patients with earlystage disease may live many years.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice